Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux

About this trial

Cardiovascular disease (CVD) causes at least 1.8 million European deaths annually, exceeding fatalities from cancer, chronic respiratory disease, and diabetes. Consequently, the fight against CVD has become the main priority of the World Health Organization. In the pursuit of understanding and treating CVD, cardiac magnetic resonance imaging (CMR) has remained the only modality capable of providing a comprehensive assessment of the heart's function and structure without harmful radiation. Unfortunately, current CMR systems remain too slow, too complex, require highly trained specialists and, as such, have presented a barrier to a wider adoption of CMR. The aim of CARDIO-IRM is to unleash the full potential of CMR to transform patient trajectories by introducing a fast, one-click, fully automated, and comprehensive imaging pipeline applicable to diagnosis, prognosis, and therapy selection in cardiology.

Eligibility criteria

Qualifiers

Adult patient (over 18 years of age) requiring an MRI scan as part of their care.

Male or female.

Affiliated or beneficiary of a social security scheme

Having given his/her oral no objection after having read the information note

Disqualifiers

Patient unable to give oral consent (guardianship, non-French speaker, etc.)

Patient deprived of liberty

Patient who does not meet the specific eligibility criteria for an MRI examination: pregnant women, known pathology that may interfere with acquisition (e.g. Parkinson's disease), absolute or relative contraindication to an MRI examination

Patient participating in a therapeutic interventional trial or in a period of relative exclusion in relation to another protocol

Trial design

Treatments tested in this trial

  • Cardiac MRI acquisition

Treatment groups

200 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Hospital, Bordeaux

Lead sponsor

Grant Agreement ERC SMHEART

Collaborator